This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Veronica Moreno: Innovator in Cardiovascular Treatments
Introduction
Veronica Moreno is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cardiovascular medicine through her innovative research and development of novel peptides.
Latest Patents
Moreno holds a patent for "CRHR2 peptide agonists and uses thereof." This invention relates to novel peptides that are selective corticotrophin releasing hormone receptor type 2 (CRHR2) agonists. These peptides are designed for the treatment, amelioration, or inhibition of cardiovascular conditions, including heart failure. The novel peptide agonist includes modifications such as pegylated peptides. Additionally, her invention encompasses methods for the treatment and prevention of diseases or disorders related to CRHR2 activity.
Career Highlights
Veronica Moreno is associated with Janssen Pharmaceutica NV, where she continues to advance her research in the pharmaceutical industry. Her work focuses on developing innovative solutions for cardiovascular health.
Collaborations
Some of her notable coworkers include Ronald V. Swanson and Nigel P. Shankley, who contribute to her research endeavors.
Conclusion
Veronica Moreno's work in developing CRHR2 peptide agonists represents a significant advancement in the treatment of cardiovascular conditions. Her innovative approach and collaboration with esteemed colleagues highlight her commitment to improving patient outcomes.